Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer

Virchows Archiv

Volumn 447, Issue 4, 2005, Pages 717-722

  Ito, Reiko ^a   Oue, Naohide ^b   Yoshida, Kazuhiro ^c   Kunimitsu, Kyoko ^b   Nakayama, Hirofumi ^b   Nakachi, Kei ^a   Yasui, Wataru ^b  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

CDH17; Gastric carcinoma; Immunohistochemistry; Prognosis

Indexed keywords

CADHERIN; CADHERIN 17; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG;

ARTICLE; CANCER STAGING; CANCER TISSUE; CORRELATION ANALYSIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE CARCINOMA; INTESTINE METAPLASIA; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA;

ADENOCARCINOMA; BLOTTING, WESTERN; CADHERINS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 27644555435     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-005-0015-2     Document Type: Article

References (21)

1. Angres B, Kim L, Jung R, Gessner R, Tauber R (2001) LI-cadherin gene expression during mouse intestinal development. Dev Dyn 221:182-193
2. Berndorff D, Gessner R, Kreft B, Schnoy N, Lajous-Petter A, Loch N, Reutter W, Hortsch M, Tauber R (1994) Liver-intestine cadherin: molecular cloning and characterization of a novel Ca(2+)-dependent cell adhesion molecule expressed in liver and intestine. J Cell Biol 125:1353-1369
3. Conacci-Sorrell M, Zhuringky J, Ben-Ze'ev A (2002) The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 109:987-991
4. Dantzig A, Hoskins J, Tabas L, Bright S, Shepard R, Jenkins I, Duckworth D, Sportsman J, Mackensen D, Paul R Jr (1994) Association of intestinal peptide transport with a protein related to the cadherin superfamily. Science 264:430-433
5. Gessner R, Tauber R (2000) Intestinal cell adhesion molecules. Liver-intestine cadherin. Ann NY Acad Sci 915:136-143
6. Hinoi T, Lucas PC, Kuick R, Hanash S, Cho KR, Fearon ER (2002) CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. Gastroenterology 123:1565-1577
7. Japanese Classification of Gastric Carcinoma, 1st English edn. Kanehara, Tokyo, pp 38-65
8. Ko S, Chu K, Luk J, Wong B, Yuen S, Leung S, Wong J (2004) Overexpression of LI-cadherin in gastric cancer is associated with lymph node metastasis. Biochem Biophys Res Commun 319:562-568
9. Ko S, Chu K-M, Luk JM-C, Wong BW-Y, Yuen S-T, Leung S-Y, Wong J (2005) CDX2 co-localized with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach. J Pathol 205:615-622
10. Kreft B, Berndorff D, Bottinger A, Finnemann S, Wedlich D, Hortsch M, Tauber R, Gessner R (1997) LI-cadherin-mediated cell-cell adhesion does not require sytoplasmic interactions. J Cell Biol 136:1109-1121
11. Lauren P (1965) The two histological main types of gastric carcinoma. Diffuse and so-called intestinal type carcinoma: an attempt at histological classification. Acta Pathol Microbiol Scand 64:31-49
12. Mayer B, Johnson J, Leitl F, Jauch K, Heiss M, Schildberg F, Birchmeier W, Funke I (1993) E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 53:1690-1695
13. Mizoshita T, Tsukamoto T, Inada K, Ogasawara N, Hirata A, Kato S, Joh T, Itoh M, Yamamura Y, Tatematsu M (2004) Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa. Pathol Int 54:392-400
14. Oue N, Shigeishi H, Kuniyasu H, Yokozaki H, Kuraoka K, Ito R, Yasui W (2001) Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma. Int J Cancer 93:805-809
15. Silberg D, Swain G, Suh E, Traber P (2000) Cdx1 and Cdx2 expression during intestinal development. Gastroenterology 119:661-671
16. Sobin L, Wittekind C (1997) TNM classification of malignant tumors, 5th edn. Wiley-Liss, New York, pp 59-62
17. Takamura M, Sakamoto M, Ino Y, Shimamura T, Ichida T, Asakura H, Hirohashi S (2003) Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas. Cancer Sci 94:425-430
18. Wong BW, Luk JM, Ng IO, Hu MY, Liu KD, Fan ST (2003) Identification of liver-intestine cadherin in hepatocellular carcinoma - a potential disease marker. Biochem Biophys Res Commun 311:618-624
19. Yasui W, Sano T, Nishimura K, Kitadai Y, Ji ZQ, Yokozaki H, Ito H, Tahara E (1993) Expression of P-cadherin in gastric carcinomas and its reduction in tumor progression. Int J Cancer 54:49-52
20. Yasui W, Oue N, Ito R, Kuraoka K, Nakayama H (2004) Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implication. Cancer Sci 95:385-392
21. Yuasa Y, Nagasaki H, Akiyama Y, Sakai H, Nakajima T, Ohkura Y, Takizawa T, Koike M, Tani M, Iwai T, Sugihara K, Imai K, Nakachi K (2005) Relationship between Cdx2 gene methylation aid dietary factors in gastric cancer patients. Carcinogenesis 26:193-200